✦ LIBER ✦

Cross-linked Peptoid-Based Dimerization Inhibitors of HIV-1 Protease

✍ Scribed by Song-Gil Lee; Jean Chmielewski

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 279 KB
Volume: 11
Category: Article
ISSN: 1439-4227
DOI: 10.1002/cbic.201000248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Small-Molecule Inhibitors of HIV-1 Prote

Small-Molecule Inhibitors of HIV-1 Protease Dimerization Derived from Cross-Linked Interfacial Peptides

✍ Michael D. Shultz; Michael J. Bowman; Young-Wan Ham; Xuimin Zhao; George Tora; J 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Small-Molecule Inhibitors of HIV-1 Prote

Small-Molecule Inhibitors of HIV-1 Protease Dimerization Derived from Cross-Linked Interfacial Peptides

✍ Michael D. Shultz; Michael J. Bowman; Young-Wan Ham; Xuimin Zhao; George Tora; J 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Novel strategies for targeting the dimer

Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides

✍ Michael J. Bowman; Jean Chmielewski 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 314 KB 👁 1 views

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of a Covalently Linked HIV-1 Protease Dimer Analogue and Peptidomimetic Inhibitors

✍ Yoshiaki Kiso 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

ChemInform Abstract: Simple cis-Epoxide-

ChemInform Abstract: Simple cis-Epoxide-Based Inhibitors of HIV-1 Protease.

✍ A. D. ABELL; D. A. HOULT; D. A. BERGMAN; D. P. FAIRLIE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Physiologically based pharmacokinetics o

Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor

✍ Akiko Kiriyama; Tomoyuki Nishiura; Hirokazu Yamaji; Kanji Takada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The effects of dose on the pharmacokinetic characteristics of KNI-272 were evaluated in rats after intravenous (iv) administration. The plasma kinetics of KNI-272 were dose-independent within a dose range of 1.0 to 10.0 mg/kg. However, when the dose was increased to 50.0 mg/kg, the area under the pl